ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Layal Al Mahmasani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0661-4383; OpenAlex author ID A5071506648. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies. Co-author DOI 10.1007/s11912-026-01812-4 ↗
Precision Oncology in Pancreatic Cancer and Future Treatment Directions. Co-author DOI 10.1016/j.soc.2025.03.002 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.63
- Paper Precision Oncology in Pancreatic Cancer and Future Treatment Directions. DOI 10.1016/j.soc.2025.03.002 ↗
Noura Abbas · 1 shared paper, 2026 · strength 0.43
- Paper Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies. DOI 10.1007/s11912-026-01812-4 ↗
Ali I. Shamseddine · 1 shared paper, 2026 · strength 0.43
- Paper Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies. DOI 10.1007/s11912-026-01812-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.